Products – Jellatech

Human Type I Atelo-Collagen

Revolutionizing biomaterials with bio-identical human collagen.

Jellatech’s Human Type I Atelo-Collagen is a highly purified, full-length, triple-helical collagen that is bio-identical to native human tissue-derived Type I collagen. With telopeptide regions removed, it offers superior biocompatibility and reduced immunogenicity, making it ideal for applications requiring high purity and safety. Its purified form supports consistent cell attachment, fibrillar gelation, and controlled matrix remodeling making it especially well-suited for cell culture models, drug delivery systems, and injectable biomaterials.

Currently offered for research-use only, this collagen is designed to meet the highest standards for cellular and tissue-engineering applications in academic and industrial settings. Contact us below for more information and orders.

Key Features:

Bio-Identical Composition
Human collagen with an amino acid sequence and triple-helical structure identical to native human Type I collagen. Identical to the structural and functional properties of tissue-derived collagen without the variability or immunogenic risk that animal-derived can pose.
Ethical & Safely Produced
Produced from isolated human cells instead of extracted from human donor tissue, ensuring a more ethical, reliable, consistent and safe production process.
High Purity for Demanding Applications
Suitable for advanced research in tissue engineering, regenerative medicine, cell culture, and biomaterials development.

Research Applications

3D Cell Culture & Organoids
Provides a defined, human-relevant extracellular matrix (ECM) for cultivating primary cells, stem cells, and organoids in physiologically relevant environments.
Tissue Engineering Scaffolds
Functions as a structural biomaterial for engineering human tissues such as skin, tendon, bone, and cornea in vitro.
Biomaterials & Coatings
Serves as a bioactive coating for cultureware, implants, or microcarriers to promote human cell adhesion, migration, and differentiation.
Wound Healing Studies
Enables high-fidelity modeling of ECM remodeling, fibroblast behavior, and collagen deposition in wound repair.
Cosmetic and Dermatological R&D
Supports mechanistic studies of collagen synthesis, degradation, and skin regeneration, aiding the development of novel anti-aging or therapeutic formulations.

Future Use Potential

While currently designated for research-use only, Jellatech’s collagen design and production platform position it well for future development into clinical- or industrial-grade biomaterials. Applications include:

Regenerative Medicine & Implants
Potential use as a bioresorbable scaffold or injectable matrix for tissue regeneration and soft tissue augmentation.
Bioengineered Skin & Grafts
Integration into clinical skin substitutes and wound dressings for burn or trauma patients.
Injectables & Fillers
Use in aesthetic medicine as a next-generation, non-animal-based dermal filler.
Bioprinting & Biofabrication
Inclusion in bioinks for printing anatomically precise tissue constructs with human-relevant ECM support.
Cell Therapies & Transplant Platforms
Development of ex vivo ECM environments to enhance cell survival, function, and integration post-transplantation.

Specifications (typical values):

Source: Human cell derived
Formulation: Lyophilized or solubilized in dilute acid (0.01 N HCl)
Molecular Weight: ~300 kDa
Purity: >95% (Silver-Staining SDS-PAGE)
Triple-Helix Integrity: Verified by circular dichroism and thermal melt

Human Type I Telo-Collagen

Human type I telo-collagen with intact telopeptide regions, offers exceptional biomimicry and mechanical integrity. Its preserved telopeptides enable superior fibrillogenesis and tissue integration, promoting natural cell adhesion and long-term structural support.

Together, these collagen types offer complementary advantages for a range of therapeutic and aesthetic applications, tailored by immunogenicity, mechanical need, and tissue interaction. Jellatech’s Human Type I Telo-Collagen – coming soon.